Patent · US Active

Imidazole amines as modulators of kinase activity

US9145392B2 · kind B2 · utility

4Cited by

0References

26Claims

0Family size

Assignee

Merck Patent GmbH · DE

Inventors

Ruoxi Lan · Waltham, US
Bayard R. Huck · Sudbury, US
Yufang Xiao · Lexington, US
Xiaoling Chen · Sharon, US
Lizbeth Celeste Deselm · Melrose, US
Hui Qiu · Lexington, US
Constantin Neagu · Belmont, US
Donald Bankston · Dracut, US
Christopher Charles Victor Jones · Arlington, US

Key dates

Filing date	Sep 12, 2012
Grant date	Sep 29, 2015
Priority date	—
Expiry date	Sep 12, 2032

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D491/107
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention provides novel imidazole amine compounds according to Formula (I) and Formula (II) their manufacture and use for the treatment of hyperproliferative diseases, such as cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.